Objective:
To explore the role of cryopreservation in the commercialization of cell therapies and its impact on cell viability.
Approach:
- Interview: Discussion with John Morris, CEO of Asymptote, about the intricacies of cryopreservation in cell therapy.
Key Findings:
- Cryopreservation is essential for the efficient storage and transport of cell therapies.
- Maintaining cell viability during the freezing process is critical for successful outcomes.
Interpretation:
Conclusion:
Sources:
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
